Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00554
|
|||||
| Drug Name |
Emetine
|
|||||
| Synonyms |
EMETINE; Emetin; Cephaeline methyl ether; Methyl cephaeline; 6',7',10,11-Tetramethoxyemetan; Emetine hydrochloride; Emetine [BAN]; Cephaline-O-methyl ether; UNII-X8D5EPO80M; Emetan, 6',7',10,11-tetramethoxy-; HSDB 2150; TCMDC-125531; EINECS 207-592-1; BRN 0100829; X8D5EPO80M; CHEMBL50588; GNF-PF-196; Emetine dihydrochloride hydrate; Ipecine; Methylcephaeline; DSSTox_CID_2980; DSSTox_RID_76816; DSSTox_GSID_22980
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Hepatitis virus infection [ICD11: 1E5Z] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C29H40N2O4
|
|||||
| Canonical SMILES |
CCC1CN2CCC3=CC(=C(C=C3C2CC1CC4C5=CC(=C(C=C5CCN4)OC)OC)OC)OC
|
|||||
| InChI |
InChI=1S/C29H40N2O4/c1-6-18-17-31-10-8-20-14-27(33-3)29(35-5)16-23(20)25(31)12-21(18)11-24-22-15-28(34-4)26(32-2)13-19(22)7-9-30-24/h13-16,18,21,24-25,30H,6-12,17H2,1-5H3/t18-,21-,24+,25-/m0/s1
|
|||||
| InChIKey |
AUVVAXYIELKVAI-CKBKHPSWSA-N
|
|||||
| CAS Number |
CAS 483-18-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 480.6 | Topological Polar Surface Area | 52.2 | ||
| Heavy Atom Count | 35 | Rotatable Bond Count | 7 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
4.7
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:4781
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||||
| 2 | Potential role of drug transporters in the pathogenesis of medically intractable epilepsy. Epilepsia. 2005 Feb;46(2):224-35. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.